We are live on ! Find out more
ORTX

Orchard Therapeutics plc American Depositary Shares
ORTX

Delisted

ORTX was delisted on the 23rd of January, 2024.

Back to rankings

47 hedge funds and large institutions have $24.7M invested in Orchard Therapeutics plc American Depositary Shares in 2022 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 12 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

6% less funds holding

Funds holding: 50 → 47 (-3)

18% less capital invested

Capital invested by funds: $30.2M → $24.7M (-$5.56M)

20% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 10

25% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 12

Holders
47
Holders Change
-3
Holders Change %
-6%
% of All Funds
0.81%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
9
Reduced
12
Closed
10
Calls
$6K
Puts
–
Net Calls
+$6K
Net Calls Change
-$4K

Top Buyers

Rank Fund Capital Flow
1
CA
CHI Advisors
New York
+$1.49M
2
Citadel Advisors
Citadel Advisors
Florida
+$1.26M
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$466K
4
Renaissance Technologies
Renaissance Technologies
New York
+$306K
5
MIAN
Mariner Independent Advisor Network
Kansas
+$288K

Top Sellers

Rank Fund Capital Flow
1
Artisan Partners
Artisan Partners
Wisconsin
-$1.94M
2
RCM
RA Capital Management
Massachusetts
-$1.78M
3
JP Morgan Chase
JP Morgan Chase
New York
-$765K
4
UOC
UBS O'Connor
Illinois
-$368K
5
GCP
GSA Capital Partners
United Kingdom
-$360K
Name Holding Trade Value Shares
Change 		Change in
Stake
CS
26
Cannell & Spears
New York
$11K -$685 -123 -5%
Two Sigma Advisers
27
Two Sigma Advisers
New York
$10K +$10.9K +1,950 New
AFG
28
Allegheny Financial Group
Pennsylvania
$8K +$9.32K +1,675 New
IIA
29
IPG Investment Advisors
California
$7.05K – – –
Wells Fargo
30
Wells Fargo
California
$7K – – –
TSS
31
Two Sigma Securities
New York
$7K +$7.7K +1,383 New
HIC
32
Holderness Investments Company
North Carolina
$7K +$8.2K +1,473 New
OC
33
Oppenheimer & Co
New York
$6K -$1.34K -240 -17%
HighTower Advisors
34
HighTower Advisors
Illinois
$6K – – –
RPCA
35
Running Point Capital Advisors
California
$5K -$390 -70 -7%
CWM
36
Connecticut Wealth Management
Connecticut
$5K – – –
IAA
37
Ironsides Asset Advisors
North Carolina
$5K – – –
APA
38
American Portfolios Advisors
New York
$3.19K – – –
UBS Group
39
UBS Group
Switzerland
$2K -$28 -5 -1%
Citigroup
40
Citigroup
New York
$1K -$27.6K -4,955 -98%
Barclays
41
Barclays
United Kingdom
$1K – – –
Osaic Holdings
42
Osaic Holdings
Arizona
$1K – – –
Artisan Partners
43
Artisan Partners
Wisconsin
– -$1.94M -332,274 Closed
RCM
44
RA Capital Management
Massachusetts
– -$1.78M -304,089 Closed
GCP
45
GSA Capital Partners
United Kingdom
– -$360K -61,640 Closed
D.E. Shaw & Co
46
D.E. Shaw & Co
New York
– -$132K -22,627 Closed
New York State Common Retirement Fund
47
New York State Common Retirement Fund
New York
– -$67K -11,501 Closed
State Street
48
State Street
Massachusetts
– -$64K -11,037 Closed
SEI Investments
49
SEI Investments
Pennsylvania
– -$20K -3,415 Closed
LG
50
Lane Generational
Massachusetts
– -$6K -1,083 Closed
1
2
3

ORTX Hedge Fund Activity: Q3 2022 in Review

47 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Orchard Therapeutics plc American Depositary Shares (ORTX) for Q3 2022, worth a combined $24.7M — down 18% from $30.2M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of ORTX and 8 opened new positions — a net loss of 2 holders — while 12 trimmed existing stakes and 9 added.

The largest buyer was CHI Advisors, adding an estimated $1.49M. The largest seller was Artisan Partners, exiting entirely with an estimated $1.94M sold.

  • 47 institutional investors held Orchard Therapeutics plc American Depositary Shares (ORTX) as of Q3 2022, down from 50 in Q2 2022.
  • Funds reported $24.7M of Orchard Therapeutics plc American Depositary Shares stock for Q3 2022, down 18% quarter-over-quarter.
  • 8 funds opened new Orchard Therapeutics plc American Depositary Shares positions in Q3 2022 and 10 closed out, a net change of -2 holders.
  • The largest Orchard Therapeutics plc American Depositary Shares buyer in Q3 2022 was CHI Advisors, an estimated $1.49M added.
  • The largest Orchard Therapeutics plc American Depositary Shares seller in Q3 2022 was Artisan Partners, an estimated $1.94M sold.

Based on aggregated 13F filings for Q3 2022.